These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34878362)

  • 1. A sequential test to compare the real-time fatality rates of a disease among multiple groups with an application to COVID-19 data.
    Qu Y; Yin Lee C; Lam KF
    Stat Methods Med Res; 2022 Feb; 31(2):348-360. PubMed ID: 34878362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.
    Ke Y; Cui J; Wong Y
    J Epidemiol Glob Health; 2021 Mar; 11(1):42-45. PubMed ID: 33009735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Analysis of Real-Time Fatality Rate in the Initial Stage of COVID-19.
    Zhou C; Fang J; Mao M
    Entropy (Basel); 2023 Jul; 25(7):. PubMed ID: 37509975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.
    Mizumoto K; Chowell G
    Emerg Infect Dis; 2020 Jun; 26(6):1251-1256. PubMed ID: 32168464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].
    Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):145-151. PubMed ID: 32064853
    [No Abstract]   [Full Text] [Related]  

  • 7. A test for constant fatality rate of an emerging epidemic: with applications to severe acute respiratory syndrome in Hong Kong and Beijing.
    Lam KF; Deshpande JV; Lau EHY; Naik-Nimbalkar UV; Yip PSF; Xu Y
    Biometrics; 2008 Sep; 64(3):869-876. PubMed ID: 18047531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemic trend of COVID-19 in Chinese mainland].
    Zhu ZB; Zhong CK; Zhang KX; Dong C; Peng H; Xu T; Wang AL; Guo ZR; Zhang YH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):620-624. PubMed ID: 32125133
    [No Abstract]   [Full Text] [Related]  

  • 9. Spatial epidemic dynamics of the COVID-19 outbreak in China.
    Kang D; Choi H; Kim JH; Choi J
    Int J Infect Dis; 2020 May; 94():96-102. PubMed ID: 32251789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.
    Peng Y; Xu B; Sun B; Han G; Zhou YH
    J Infect Public Health; 2020 Jun; 13(6):890-892. PubMed ID: 32451257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the COVID-19 epidemic and correlation with population emigration from Wuhan, China.
    Chen ZL; Zhang Q; Lu Y; Guo ZM; Zhang X; Zhang WJ; Guo C; Liao CH; Li QL; Han XH; Lu JH
    Chin Med J (Engl); 2020 May; 133(9):1044-1050. PubMed ID: 32118644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatio-temporal distribution characteristics of COVID-19 in China: a city-level modeling study.
    Ma Q; Gao J; Zhang W; Wang L; Li M; Shi J; Zhai Y; Sun D; Wang L; Chen B; Jiang S; Zhao J
    BMC Infect Dis; 2021 Aug; 21(1):816. PubMed ID: 34391402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the instant case fatality rate of COVID-19 in China.
    Mi YN; Huang TT; Zhang JX; Qin Q; Gong YX; Liu SY; Xue HM; Ning CH; Cao L; Cao YX
    Int J Infect Dis; 2020 Aug; 97():1-6. PubMed ID: 32339723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings.
    Ji T; Chen HL; Xu J; Wu LN; Li JJ; Chen K; Qin G
    Clin Infect Dis; 2020 Sep; 71(6):1454-1460. PubMed ID: 32255183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fitting and forecasting the trend of COVID-19 by SEIR(+CAQ) dynamic model].
    Wei YY; Lu ZZ; Du ZC; Zhang ZJ; Zhao Y; Shen SP; Wang B; Hao YT; Chen F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Apr; 41(4):470-475. PubMed ID: 32113198
    [No Abstract]   [Full Text] [Related]  

  • 18. Revisiting the Effects of High-Speed Railway Transfers in the Early COVID-19 Cross-Province Transmission in Mainland China.
    Chan CH; Wen TH
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34199158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent Gender Differences in COVID-19 in Mainland China: Comparative Study.
    Qian J; Zhao L; Ye RZ; Li XJ; Liu YL
    Clin Infect Dis; 2020 Dec; 71(9):2488-2494. PubMed ID: 32473009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method to monitor COVID-19 fatality rate in real-time, a key metric to guide public health policy.
    Qu Y; Lee CY; Lam KF
    Sci Rep; 2022 Oct; 12(1):18277. PubMed ID: 36316534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.